News-Medical.Net on MSN
Metformin fails to improve insulin resistance in type 1 diabetes
Metformin treatment in type 1 diabetes lowers insulin dosage but does not improve insulin resistance, highlighting its ...
Diabetes and cancer are two of the four major non-communicable diseases identified by WHO. Their relationship is multifaceted ...
Stephen Klasko, executive-in-residence at General Catalyst, shares how AI, innovation, economic realities and revamped ...
In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader who had a bad experience with Tamiflu.
CMS has negotiated a 71% discount off the list price, or $274 for a 30-day supply, on Novo Nordisk’s semaglutide products — Ozempic and Rybelsus for diabetes and Wegovy for weight loss — through the ...
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and gastrointestinal oncology indications, reports ...
A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar ...
TEL AVIV, Israel, Nov. 26, 2025 /PRNewswire/ -Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused ...
The Family Health Care Institute’s bulletin (one of the King Hussein Foundation institutes), today, Wednesday, provides ...
MedPage Today on MSN
Medicare Prices to Drop Up to 85% on Drugs for Weight-Loss, Cancer, Asthma, and More
The negotiated prices are a result of a program passed by Congress in 2022 as part of the Inflation Reduction Act (IRA). The ...
Keratosis pilaris, also known as 'chicken skin', is a common and harmless condition that causes small bumps on the skin ...
Mumbai: Eris Lifesciences Limited has announced that its Board of Directors has approved the acquisition of the balance 30 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results